Skip to content
Welcome To Atlantic Books! Upto 75% off Across Various Categories.
Upto 75% off Across Various Categories.

Beta2-Agonists In Asthma Treatment (Vol. 106)

by Romain Pauwels , Paul O'Byrne
Save 30% Save 30%
Original price Rs. 13,788.00
Original price Rs. 13,788.00 - Original price Rs. 13,788.00
Original price Rs. 13,788.00
Current price Rs. 9,652.00
Rs. 9,652.00 - Rs. 9,652.00
Current price Rs. 9,652.00

Estimated Shipping Date

Ships in 1-2 Days

Free Shipping on orders above Rs. 1000

New Year Offer - Use Code ATLANTIC10 at Checkout for additional 10% OFF

Request Bulk Quantity Quote
Book cover type: Hardcover
  • ISBN13: 9780824794965
  • Binding: Hardcover
  • Subject: Medical, Nursing and Health Sciences
  • Publisher: T&F
  • Publisher Imprint: Mar Dekker
  • Publication Date:
  • Pages: 459
  • Original Price: GBP 123.0
  • Language: English
  • Edition: N/A
  • Item Weight: 1000 grams

About the Book This authoritative, timely resource analyzes every important topic related to the most frequently prescribed anti-asthma medications-comprehensively examining the use of beta2-agonists from molecular interactions with the beta-receptor to clinical and therapeutic applications in acute and chronic conditions. <br>Includes lively discussion sections that address controversies involving the use of beta2-agonists and synthesizes current information into practical treatment guidelines <br>Written by world-renowned experts representing prestigious institutions in 12 countries, Beta2-Agonists in Asthma Treatment<br><li>summarizes the history of beta-agonists in asthma treatment <br></li><li>explains the molecular action and effect of beta2-agonists on airway effector cells and inflammation <br></li><li>discusses in detail beta2-agonist pharmacokinetics <br></li><li>reviews inhalation devices and techniques <br></li><li>compares the pharmacological characteristics of long-acting versus short-acting beta2-agonists <br></li><li>addresses the possible influence of beta2-agonists in the deterioration of asthmatic conditions and increased mortality <br></li><li>delineates the role of beta2-agonists in treating acute and chronic asthma in both children and adults <br></li><li>and much more </li>